Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 known ✓ | P03956 | 10/20 | 0.41 |
| ▸ | HTR2A known ✓ | P28223 | 1/20 | 0.41 |
| ▸ | KCNH2 known ✓ | Q12809 | 1/20 | 0.40 |
| ▸ | MMP7 known ✓ | P09237 | 6/20 | 0.39 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.54 |
| ▸ | MMP2 | P08253 | 16/20 | 0.41 |
| ▸ | MMP3 | P08254 | 11/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11130193 | 1.00 | CSNK1E (0.54) | CSNK1EMMP2MMP3MMP1HTR2A | |
| Hydrochloric Acid SCHEMBL60916 | 1.00 | CSNK1E (0.54) | CSNK1EMMP2MMP3MMP1HTR2A | |
| Hydrochloric Acid SCHEMBL5183324 | 1.00 | CSNK1E (0.54) | CSNK1EMMP2MMP3MMP1HTR2A | |
| Hydrochloric Acid SCHEMBL5086708 | 1.00 | CSNK1E (0.54) | CSNK1EMMP2MMP3MMP1HTR2A | |
| Hydrochloric Acid SCHEMBL875996 | 1.00 | CSNK1E (0.54) | CSNK1EMMP2MMP3MMP1HTR2A | |
| Hydrochloric Acid SCHEMBL11576013 | 1.00 | CSNK1E (0.54) | CSNK1EMMP2MMP3MMP1HTR2A | |
| Hydrochloric Acid SCHEMBL82688 | 1.00 | CSNK1E (0.54) | CSNK1EMMP2MMP3MMP1HTR2A | |
| Hydrochloric Acid SCHEMBL59932 | 1.00 | CSNK1E (0.54) | CSNK1EMMP2MMP3MMP1HTR2A | |
| Hydrochloric Acid SCHEMBL5088573 | 1.00 | CSNK1E (0.54) | CSNK1EMMP2MMP3MMP1HTR2A | |
| Hydrochloric Acid SCHEMBL1011374 | 1.00 | CSNK1E (0.54) | CSNK1EMMP2MMP3MMP1HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240353412-A1 | A METHOD AND REAGENTS FOR ENHANCING THE CHEMILUMINESCENT SIGNAL | EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG (DE) | 2024-10-24 | — | — | US | claimed |
| US-20240018073-A1 | METHOD FOR TREATING A HEAVY BYPRODUCT STREAM FROM CHLORINATED PROPANE PRODUCTION | BLUE CUBE IP LLC (US) | 2024-01-18 | — | — | US | claimed |
| CN-117043127-A | Method for treating a heavy byproduct stream from the production of propane chloride | 蓝立方知识产权有限责任公司 | 2023-11-10 | — | — | CN | claimed |
| EP-4251599-A1 | METHOD FOR TREATING A HEAVY BYPRODUCT STREAM FROM CHLORINATED PROPANE PRODUCTION | Blue Cube IP LLC (US) | 2023-10-04 | — | — | EP | claimed |
| EP-4146765-B1 | A METHOD AND REAGENTS FOR ENHANCING THE CHEMILUMINESCENT SIGNAL | EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG (DE) | 2023-07-05 | — | — | EP | claimed |
| EP-4146765-A1 | A METHOD AND REAGENTS FOR ENHANCING THE CHEMILUMINESCENT SIGNAL | EUROIMMUN Medizinische Labordiagnostika AG (DE) | 2023-03-15 | — | — | EP | claimed |
| WO-2023006581-A1 | A METHOD AND REAGENTS FOR ENHANCING THE CHEMILUMINESCENT SIGNAL | EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG (DE) | 2023-02-02 | — | — | WO | claimed |
| WO-2022115151-A1 | METHOD FOR TREATING A HEAVY BYPRODUCT STREAM FROM CHLORINATED PROPANE PRODUCTION | BLUE CUBE IP LLC (US) | 2022-06-02 | — | — | WO | claimed |
| EP-2723922-B1 | ELECTROLYTE AND ITS USE FOR THE DEPOSITION OF BLACK RUTHENIUM COATINGS AND COATINGS OBTAINED IN THIS WAY | UMICORE GALVANOTECHNIK GMBH (DE) | 2019-08-28 | — | — | EP | claimed |
| EP-3510009-A1 | PROCESSES FOR THE DEHYDROCHLORINATION OF A CHLORINATED ALKANE | Blue Cube IP LLC (US) | 2019-07-17 | — | — | EP | claimed |
| US-20190202759-A1 | PROCESSES FOR THE DEHYDROCHLORINATION OF A CHLORINATED ALKANE | BLUE CUBE IP LLC | 2019-07-04 | — | — | US | claimed |
| WO-2018048783-A1 | PROCESSES FOR THE DEHYDROCHLORINATION OF A CHLORINATED ALKANE | BLUE CUBE IP LLC (US) | 2018-03-15 | — | — | WO | claimed |
| US-20140131209-A1 | ELECTROLYTE AND ITS USE FOR THE DEPOSITION OF BLACK RUTHENIUM COATINGS AND COATINGS OBTAINED IN THIS WAY | UMICORE GALVANOTECHNIK GMBH (DE) | 2014-05-15 | — | — | US | claimed |
| EP-2723922-A2 | ELECTROLYTE AND ITS USE FOR THE DEPOSITION OF BLACK RUTHENIUM COATINGS AND COATINGS OBTAINED IN THIS WAY | Umicore Galvanotechnik GmbH (DE) | 2014-04-30 | — | — | EP | claimed |
| WO-2012171856-A2 | ELECTROLYTE AND ITS USE FOR THE DEPOSITION OF BLACK RUTHENIUM COATINGS AND COATINGS OBTAINED IN THIS WAY | UMICORE GALVANOTECHNIK GMBH (DE) | 2012-12-20 | — | — | WO | claimed |
| US-7625581-B2 | Tissue scaffolds for use in muscoloskeletal repairs | ETHICON, INC. (US) | 2009-12-01 | — | — | US | claimed |
| US-7091191-B2 | Modified hyaluronic acid for use in musculoskeletal tissue repair | ETHICON, INC. (US) | 2006-08-15 | — | — | US | claimed |
| US-20050147642-A1 | Tissue scaffolds for use in muscoloskeletal repairs | ENDO-SURGERY, INC. | 2005-07-07 | — | — | US | claimed |
| US-20050137163-A1 | Modified hyaluronic acid for use in musculoskeletal tissue repair | ADVANCED TECHNOLOGIES AND REGENERATIVE MEDICINE, LLC | 2005-06-23 | — | — | US | claimed |
| US-12582634-B2 | Synthetic methods for preparation of 4-(2-chloro-4-methoxy-5-methylphenyl)-n-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-n-prop-2-ynyl-1,3-thiazol-2-amine | NEUROCRINE BIOSCIENCES, INC. (US) | 2026-03-24 | — | — | US | disclosed |
| US-20260022311-A1 | SEMICONDUCTOR SUBSTRATE CLEANING COMPOSITION, AND METHOD FOR PRODUCING SEMICONDUCTOR SUBSTRATE USING SAME | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2026-01-22 | — | — | US | disclosed |
| US-12344586-B2 | Process for the preparation of biphenylamines | ADAMA MAKHTESHIM LTD. (IL) | 2025-07-01 | — | — | US | disclosed |
| CN-120129771-A | Aqueous composition for etching, etching method using same, and method for manufacturing semiconductor substrate | 三菱瓦斯化学株式会社 | 2025-06-10 | — | — | CN | disclosed |
| EP-4564403-A1 | SEMICONDUCTOR SUBSTRATE CLEANING COMPOSITION, AND METHOD FOR PRODUCING SEMICONDUCTOR SUBSTRATE USING SAME | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-06-04 | — | — | EP | disclosed |
| US-20250154410-A1 | COMPOSITION, AND SEMICONDUCTOR SUBSTRATE MANUFACTURING METHOD AND ETCHING METHOD USING SAME | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-05-15 | — | — | US | disclosed |
| CN-119431770-A | Modified polyphenylene ether resin, method for preparing the same, and resin composition comprising the same | 南亚塑胶工业股份有限公司 | 2025-02-14 | — | — | CN | disclosed |
| US-20250043075-A1 | MODIFIED POLYPHENYLENE ETHER RESIN, PREPARATION METHOD THEREOF, AND RESIN COMPOSITION INCLUDING THEREOF | NAN YA PLASTICS CORPORATION (TW) | 2025-02-06 | — | — | US | disclosed |
| EP-4502007-A1 | MODIFIED POLYPHENYLENE ETHER RESIN, PREPARATION METHOD THEREOF, AND RESIN COMPOSITION INCLUDING THEREOF | NAN YA PLASTICS CORPORATION (TW) | 2025-02-05 | — | — | EP | disclosed |
| US-20250011297-A1 | PROCESS AND INTERMEDIATES FOR PREPARATION OF ISOFETAMID | ADAMA MAKHTESHIM LTD. (IL) | 2025-01-09 | — | — | US | disclosed |
| EP-4485506-A1 | COMPOSITION, AND SEMICONDUCTOR SUBSTRATE MANUFACTURING METHOD AND ETCHING METHOD USING SAME | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-01-01 | — | — | EP | disclosed |
| US-12128033-B2 | Synthetic methods for preparation of 4-(2-chloro-4-methoxy-5-methylphenyl)-n-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-n-prop-2-ynyl-1,3-thiazol-2-amine | NEUROCRINE BIOSCIENCES, INC. (US) | 2024-10-29 | — | — | US | disclosed |
| US-20240353412-A1 | A METHOD AND REAGENTS FOR ENHANCING THE CHEMILUMINESCENT SIGNAL | EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG (DE) | 2024-10-24 | — | — | US | disclosed |
| CN-118791342-A | Method for optimizing TATB performance based on curing effect | 西南科技大学 | 2024-10-18 | — | — | CN | disclosed |
| EP-3774936-B1 | SOLVENT-FREE PROCESS FOR FUNCTIONALIZING ISOBUTYLENE-BASED POLYMERS | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2024-09-04 | — | — | EP | disclosed |
| US-20240238257-A1 | SYNTHETIC METHODS FOR PREPARATION OF 4-(2-CHLORO-4-METHOXY-5-METHYLPHENYL)-N-[(1S)-2-CYCLOPROPYL-1-(3-FLUORO-4-METHYLPHENYL)ETHYL]-5-METHYL-N-PROP-2-YNYL-1,3-THIAZOL-2-AMINE | SANOFI (FR) | 2024-07-18 | — | — | US | disclosed |
| EP-4211102-B1 | PROCESSES FOR PREPARING PENTACHLOROPROPANE AND TETRACHLOROPROPENE FROM DICHLOROPROPENE | BLUE CUBE IP LLC (US) | 2024-07-17 | — | — | EP | disclosed |
| CN-118159518-A | Method and intermediates for preparing ipratropium | 安道麦马克西姆有限公司 | 2024-06-07 | — | — | CN | disclosed |
| CN-112074546-B | Solvent-free process for functionalizing isobutylene-based polymers | 埃克森美孚化学专利公司 | 2024-05-28 | — | — | CN | disclosed |
| WO-2024096006-A1 | AQUEOUS COMPOSITION FOR ETCHING, ETCHING METHOD USING SAME, AND SEMICONDUCTOR SUBSTRATE MANUFACTURING METHOD | 三菱瓦斯化学株式会社 | 2024-05-10 | — | — | WO | disclosed |
| WO-2024024811-A1 | SEMICONDUCTOR SUBSTRATE CLEANING COMPOSITION, AND METHOD FOR PRODUCING SEMICONDUCTOR SUBSTRATE USING SAME | 三菱瓦斯化学株式会社 | 2024-02-01 | — | — | WO | disclosed |
| US-20240018073-A1 | METHOD FOR TREATING A HEAVY BYPRODUCT STREAM FROM CHLORINATED PROPANE PRODUCTION | BLUE CUBE IP LLC (US) | 2024-01-18 | — | — | US | disclosed |
| CN-117362503-A | Solvent-free process for functionalizing isobutylene-based polymers | 埃克森美孚化学专利公司 | 2024-01-09 | — | — | CN | disclosed |
| US-20230348345-A1 | PROCESSES FOR PREPARING PENTACHLOROPROPANE AND TETRACHLOROPROPENE FROM DICHLOROPROPENE | BLUE CUBE IP LLC | 2023-11-02 | — | — | US | disclosed |
| US-11780817-B2 | Methods for preparing Favipiravir | Weaver Labs, LLC (US) | 2023-10-10 | — | — | US | disclosed |
| EP-4251599-A1 | METHOD FOR TREATING A HEAVY BYPRODUCT STREAM FROM CHLORINATED PROPANE PRODUCTION | Blue Cube IP LLC (US) | 2023-10-04 | — | — | EP | disclosed |
| US-20230286932-A1 | SYNTHETIC METHODS FOR PREPARATION OF 4-(2-CHLORO-4-METHOXY-5-METHYLPHENYL)-N-[(1S)-2-CYCLOPROPYL-1-(3-FLUORO-4-METHYLPHENYL)ETHYL]-5-METHYL-N-PROP-2-YNYL-1,3-THIAZOL-2-AMINE | NEUROCRINE BIOSCIENCES, INC. | 2023-09-14 | — | — | US | disclosed |
| WO-2023163002-A1 | COMPOSITION, AND SEMICONDUCTOR SUBSTRATE MANUFACTURING METHOD AND ETCHING METHOD USING SAME | 三菱瓦斯化学株式会社 | 2023-08-31 | — | — | WO | disclosed |
| US-20230233534-A1 | SYNTHETIC METHODS FOR PREPARATION OF 4-(2-CHLORO-4-METHOXY-5-METHYLPHENYL)-N-[(1S)-2-CYCLOPROPYL-1-(3-FLUORO-4-METHYLPHENYL)ETHYL]-5-METHYL-N-PROP-2-YNYL-1,3-THIAZOL-2-AMINE | NEUROCRINE BIOSCIENCES, INC. | 2023-07-27 | — | — | US | disclosed |
| EP-4211102-A1 | PROCESSES FOR PREPARING PENTACHLOROPROPANE AND TETRACHLOROPROPENE FROM DICHLOROPROPENE | Blue Cube IP LLC (US) | 2023-07-19 | — | — | EP | disclosed |
| EP-4146765-B1 | A METHOD AND REAGENTS FOR ENHANCING THE CHEMILUMINESCENT SIGNAL | EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG (DE) | 2023-07-05 | — | — | EP | disclosed |
| CN-116322668-A | Synthetic method for preparing 4- (2-chloro-4-methoxy-5-methylphenyl) -N- [ (1S) -2-cyclopropyl-1- (3-fluoro-4-methylphenyl) ethyl ] -5-methyl-N-prop-2-ynyl-1, 3-thiazol-2-amine | 纽罗克里生物科学有限公司 | 2023-06-23 | — | — | CN | disclosed |
| WO-2023082149-A1 | PROCESS AND INTERMEDIATES FOR PREPARATION OF ISOFETAMID | ADAMA MAKHTESHIM LTD. (IL) | 2023-05-19 | — | — | WO | disclosed |
| US-11649303-B2 | Solvent-free process for functionalizing isobutylene-based polymers | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2023-05-16 | — | — | US | disclosed |
| EP-4164604-A2 | SYNTHETIC METHODS FOR PREPARATION OF 4-(2-CHLORO-4-METHOXY-5-METHYLPHENYL)-N-[(1S)-2-CYCLOPROPYL-1-(3-FLUORO-4-METHYLPHENYL)ETHYL]-5-METHYL-N-PROP-2-YNYL-1,3-THIAZOL-2-AMINE | Neurocrine Biosciences, Inc. (US) | 2023-04-19 | — | — | EP | disclosed |
| EP-4146765-A1 | A METHOD AND REAGENTS FOR ENHANCING THE CHEMILUMINESCENT SIGNAL | EUROIMMUN Medizinische Labordiagnostika AG (DE) | 2023-03-15 | — | — | EP | disclosed |
| WO-2023006581-A1 | A METHOD AND REAGENTS FOR ENHANCING THE CHEMILUMINESCENT SIGNAL | EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG (DE) | 2023-02-02 | — | — | WO | disclosed |
| US-20220380321-A1 | PROCESS FOR THE PREPARATION OF BIPHENYLAMINES | ADAMA MAKHTESHIM LTD. (IL) | 2022-12-01 | — | — | US | disclosed |
| CN-115087647-A | Synthetic method for preparing 4- (2-chloro-4-methoxy-5-methylphenyl) -N- [ (1S) -2-cyclopropyl-1- (3-fluoro-4-methylphenyl) ethyl ] -5-methyl-N-prop-2-alkynyl-1, 3-thiazol-2-amine | 纽罗克里生物科学有限公司 | 2022-09-20 | — | — | CN | disclosed |
| CN-114945552-A | Process for preparing benzidine | 阿达玛马克西姆有限公司 | 2022-08-26 | — | — | CN | disclosed |
| US-11407928-B2 | Organophilic clay based drilling fluids containing Gemini surfactant and polyacrylamide | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2022-08-09 | — | — | US | disclosed |
| WO-2022115151-A1 | METHOD FOR TREATING A HEAVY BYPRODUCT STREAM FROM CHLORINATED PROPANE PRODUCTION | BLUE CUBE IP LLC (US) | 2022-06-02 | — | — | WO | disclosed |
| EP-3999488-A1 | PROCESS FOR THE PREPARATION OF BIPHENYLAMINES | Adama Makhteshim Ltd. (IL) | 2022-05-25 | — | — | EP | disclosed |
| CN-111655832-B | Mildew-removing cleaning agent composition for hard surface | 花王株式会社 | 2022-05-17 | — | — | CN | disclosed |
| WO-2022056129-A1 | PROCESSES FOR PREPARING PENTACHLOROPROPANE AND TETRACHLOROPROPENE FROM DICHLOROPROPENE | BLUE CUBE IP LLC (US) | 2022-03-17 | — | — | WO | disclosed |
| US-20220018826-A1 | COLORIMETRIC PLASMONIC NANOSENSOR FOR DOSIMETRY OF THERAPEUTIC LEVELS OF IONIZING RADIATION | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2022-01-20 | — | — | US | disclosed |
| WO-2021250468-A2 | SYNTHETIC METHODS FOR PREPARATION OF 4-(2-CHLORO-4-METHOXY-5- METHYLPHENYL)-V-[(LS)-2-CYCLOPROPYL-L-(3-FLUORO-4-METHYLPHENYL)ETHYL]-5-METHYL-V-PROP-2-YNYL-L,3-THIAZOL-2-AMINE | NEUROCRINE BIOSCIENCES, INC. (US) | 2021-12-16 | — | — | WO | disclosed |
| US-20210355090-A1 | METHODS FOR PREPARING FAVIPIRAVIR | Weaver Labs, LLC (US) | 2021-11-18 | — | — | US | disclosed |
| CN-113302228-A | Water-absorbent resin particles and method for producing same | 三大雅株式会社 | 2021-08-24 | — | — | CN | disclosed |
| CN-113227218-A | Water-absorbent resin particles and method for producing same | 三大雅株式会社 | 2021-08-06 | — | — | CN | disclosed |
| WO-2021111179-A1 | SYNTHETIC METHOD FOR PREPARATION OF 4-(2-CHLORO-4-METHOXY-5-METHYLPHENYL)-N-[(1S)-2-CYCLOPROPYL-1-(3-FLUORO-4-METHYLPHENYL)ETHYL]-5-METHYL-N-PROP-2-YNYL-1,3-THIAZOL-2-AMINE | NEUROCRINE BIOSCIENCES, INC. (US) | 2021-06-10 | — | — | WO | disclosed |
| US-20210094897-A1 | IMPROVED PROCESS FOR PREPARING A CHLORINATED ALKENE BY CAUSTIC DEHYDROCHLORINATION OF A CHLORINATED ALKANE IN A JET LOOP REACTOR | BLUE CUBE IP LLC (US) | 2021-04-01 | — | — | US | disclosed |
| EP-3774936-A1 | SOLVENT-FREE PROCESS FOR FUNCTIONALIZING ISOBUTYLENE-BASED POLYMERS | ExxonMobil Chemical Patents Inc. (US) | 2021-02-17 | — | — | EP | disclosed |
| EP-3772948-A1 | COMPOSITIONS AND METHODS FOR LONG LASTING DISINFECTION | Rhodia Operations (FR) | 2021-02-17 | — | — | EP | disclosed |
| EP-3772947-A1 | COMPOSITIONS AND METHODS FOR LONG LASTING DISINFECTION | Rhodia Operations (FR) | 2021-02-17 | — | — | EP | disclosed |
| WO-2021014437-A1 | PROCESS FOR THE PREPARATION OF BIPHENYLAMINES | ADAMA MAKHTESHIM LTD. (IL) | 2021-01-28 | — | — | WO | disclosed |
| US-20210017304-A1 | Solvent-Free Process for Functionalizing Isobutylene-Based Polymers | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2021-01-21 | — | — | US | disclosed |
| CN-112074546-A | Solvent-free process for functionalizing isobutylene-based polymers | 埃克森美孚化学专利公司 | 2020-12-11 | — | — | CN | disclosed |
| CN-111936456-A | Improved process for the preparation of chlorinated alkenes by caustic dehydrochlorination of chlorinated alkanes in a jet loop reactor | 蓝立方知识产权有限责任公司 | 2020-11-13 | — | — | CN | disclosed |
| US-20200325381-A1 | ORGANOPHILIC CLAY BASED DRILLING FLUIDS CONTAINING GEMINI SURFACTANT AND POLYACRYLAMIDE | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2020-10-15 | — | — | US | disclosed |
| CN-111655832-A | Mildew-removing cleaning agent composition for hard surface | 花王株式会社 | 2020-09-11 | — | — | CN | disclosed |
| WO-2020144948-A1 | WATER ABSORBENT RESIN PARTICLES AND PRODUCTION METHOD THEREFOR | ＳＤＰグローバル株式会社 | 2020-07-16 | — | — | WO | disclosed |
| US-10709786-B2 | Clear aqueous solution | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2020-07-14 | — | — | US | disclosed |
| US-10703959-B2 | Functionalized silicate nanoparticle composition, removing and exfoliating asphaltenes with same | BAKER HUGHES, A GE COMPANY, LLC (US) | 2020-07-07 | — | — | US | disclosed |
| WO-2020137241-A1 | WATER-ABSORBENT RESIN PARTICLES AND METHOD FOR PRODUCING SAME | ＳＤＰグローバル株式会社 | 2020-07-02 | — | — | WO | disclosed |
| WO-2019199877-A1 | COMPOSITIONS AND METHODS FOR LONG LASTING DISINFECTION | RHODIA OPERATIONS (FR) | 2019-10-17 | — | — | WO | disclosed |
| WO-2019199886-A1 | COMPOSITIONS AND METHODS FOR LONG LASTING DISINFECTION | RHODIA OPERATIONS (FR) | 2019-10-17 | — | — | WO | disclosed |
| WO-2019195251-A1 | IMPROVED PROCESS FOR PREPARING A CHLORINATED ALKENE BY CAUSTIC DEHYDROCHLORINATION OF A CHLORINATED ALKANE IN A JET LOOP REACTOR | BLUE CUBE IP LLC (US) | 2019-10-10 | — | — | WO | disclosed |
| WO-2019195111-A1 | SOLVENT-FREE PROCESS FOR FUNCTIONALIZING ISOBUTYLENE-BASED POLYMERS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2019-10-10 | — | — | WO | disclosed |
| US-20190300460-A1 | PROCESS FOR IMPROVING THE PRODUCTION OF A CHLORINATED ALKENE BY CAUSTIC DEYDROCHLORINATION OF A CHLORINATED ALKANE BY RECYCLING | BLUE CUBE IP LLC | 2019-10-03 | — | — | US | disclosed |
| US-10428160-B2 | Colorimetric hydrogel based nanosensor for detection of therapeutic levels of ionizing radiation | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2019-10-01 | — | — | US | disclosed |
| EP-2952189-B1 | CLEAR AQUEOUS SOLUTION | SENJU PHARMA CO (JP) | 2019-09-18 | — | — | EP | disclosed |
| EP-2723922-B1 | ELECTROLYTE AND ITS USE FOR THE DEPOSITION OF BLACK RUTHENIUM COATINGS AND COATINGS OBTAINED IN THIS WAY | UMICORE GALVANOTECHNIK GMBH (DE) | 2019-08-28 | — | — | EP | disclosed |
| EP-3510009-A1 | PROCESSES FOR THE DEHYDROCHLORINATION OF A CHLORINATED ALKANE | Blue Cube IP LLC (US) | 2019-07-17 | — | — | EP | disclosed |
| US-20190202759-A1 | PROCESSES FOR THE DEHYDROCHLORINATION OF A CHLORINATED ALKANE | BLUE CUBE IP LLC | 2019-07-04 | — | — | US | disclosed |
| US-9968679-B2 | Clear aqueous solution | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2018-05-15 | — | — | US | disclosed |
| WO-2018048783-A1 | PROCESSES FOR THE DEHYDROCHLORINATION OF A CHLORINATED ALKANE | BLUE CUBE IP LLC (US) | 2018-03-15 | — | — | WO | disclosed |
| US-20180066074-A1 | Colorimetric Hydrogel Based Nanosensor for Detection of Therapeutic Levels of Ionizing Radiation | BANNER HEALTH - AN ARIZONA NONPROFIT CORPORATION | 2018-03-08 | — | — | US | disclosed |
| US-9777251-B2 | Liquid composition for removing titanium nitride, semiconductor-element cleaning method using same, and semiconductor-element manufacturing method | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2017-10-03 | — | — | US | disclosed |
| US-20170247599-A1 | FUNCTIONALIZED SILICATE NANOPARTICLE COMPOSITION, REMOVING AND EXFOLIATING ASPHALTENES WITH SAME | BAKER HUGHES INCORPORATED | 2017-08-31 | — | — | US | disclosed |
| US-20170212037-A1 | COLORIMETRIC PLASMONIC NANOSENSOR FOR DOSIMETRY OF THERAPEUTIC LEVELS OF IONIZING RADIATION | BANNER HEALTH, AN ARIZONA NONPROFIT CORPORATION | 2017-07-27 | — | — | US | disclosed |
| US-9683163-B2 | Functionalized silicate nanoparticle composition, removing and exfoliating asphaltenes with same | BAKER HUGHES INCORPORATED (US) | 2017-06-20 | — | — | US | disclosed |
| US-20160281038-A1 | LIQUID COMPOSITION FOR REMOVING TITANIUM NITRIDE, SEMICONDUCTOR-ELEMENT CLEANING METHOD USING SAME, AND SEMICONDUCTOR-ELEMENT MANUFACTURING METHOD | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2016-09-29 | — | — | US | disclosed |
| WO-2016149454-A1 | FUNCTIONALIZED SILICATE NANOPARTICLE COMPOSITION, REMOVING AND EXFOLIATING ASPHALTENES WITH SAME | BAKER HUGHES INCORPORATED (US) | 2016-09-22 | — | — | WO | disclosed |
| EP-2363498-B1 | METHOD FOR QUANTITATIVELY DETERMINING CHOLESTEROL IN LOW-DENSITY LIPOPROTEINS, REAGENT FOR QUANTITATIVE DETERMINATION, AND QUANTITATIVE DETERMINATION KIT | KYOWA MEDEX CO LTD (JP) | 2016-05-25 | — | — | EP | disclosed |
| US-9271911-B2 | Quarternary amine surfactant cleaner | OAP Cleaner LLC | 2016-03-01 | — | — | US | disclosed |
| US-20150366969-A1 | Clear Aqueous Solution | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2015-12-24 | — | — | US | disclosed |
| EP-2952189-A1 | CLEAR AQUEOUS SOLUTION | Senju Pharmaceutical Co., Ltd. (JP) | 2015-12-09 | — | — | EP | disclosed |
| US-20150191646-A1 | FUNCTIONALIZED SILICATE NANOPARTICLE COMPOSITION, REMOVING AND EXFOLIATING ASPHALTENES WITH SAME | BAKER HUGHES INCORPORATED (US) | 2015-07-09 | — | — | US | disclosed |
| US-9012377-B2 | Functionalized silicate nanoparticle composition, removing and exfoliating asphaltenes with same | BAKER HUGHES INCORPORATED (US) | 2015-04-21 | — | — | US | disclosed |
| US-20140228564-A1 | PROCESSES OF ENANTIOSELECTIVELY FORMING AN AMINOXY COMPOUND AND AN 1,2-OXAZINE COMPOUND | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2014-08-14 | — | — | US | disclosed |
| US-20140187449-A1 | FUNCTIONALIZED SILICATE NANOPARTICLE COMPOSITION, REMOVING AND EXFOLIATING ASPHALTENES WITH SAME | BAKER HUGHES INCORPORATED (US) | 2014-07-03 | — | — | US | disclosed |
| WO-2014106007-A1 | FUNCTIONALIZED SILICATE NANOPARTICLE COMPOSITION, REMOVING AND EXFOLIATING ASPHALTENES WITH SAME | BAKER HUGHES INCORPORATED (US) | 2014-07-03 | — | — | WO | disclosed |
| US-20140171350-A1 | Cleaner | OAP Cleaner LLC | 2014-06-19 | — | — | US | disclosed |
| US-20140131209-A1 | ELECTROLYTE AND ITS USE FOR THE DEPOSITION OF BLACK RUTHENIUM COATINGS AND COATINGS OBTAINED IN THIS WAY | UMICORE GALVANOTECHNIK GMBH (DE) | 2014-05-15 | — | — | US | disclosed |
| EP-2723922-A2 | ELECTROLYTE AND ITS USE FOR THE DEPOSITION OF BLACK RUTHENIUM COATINGS AND COATINGS OBTAINED IN THIS WAY | Umicore Galvanotechnik GmbH (DE) | 2014-04-30 | — | — | EP | disclosed |
| US-8680335-B2 | Processes of enantioselectively forming an aminoxy compound and an 1,2-oxazine compound | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2014-03-25 | — | — | US | disclosed |
| WO-2013061082-A1 | ANTI-MICROBIAL COMPOSITION | BYOTROL PLC (GB) | 2013-05-02 | — | — | WO | disclosed |
| US-8377713-B2 | Detection of explosives through luminescence | REDXDEFENSE, LLC (US) | 2013-02-19 | — | — | US | disclosed |
| WO-2012171856-A2 | ELECTROLYTE AND ITS USE FOR THE DEPOSITION OF BLACK RUTHENIUM COATINGS AND COATINGS OBTAINED IN THIS WAY | UMICORE GALVANOTECHNIK GMBH (DE) | 2012-12-20 | — | — | WO | disclosed |
| US-20110223626-A1 | METHOD FOR QUANTITATIVELY DETERMINING CHOLESTEROL IN LOW-DENSITY LIPOPROTEINS,REAGENT FOR QUANTITATIVE DETERMINATION,AND QUANTITATIVE DETERMINATION KIT | KYOWA MEDEX CO., LTD. (JP) | 2011-09-15 | — | — | US | disclosed |
| US-20110224429-A1 | PROCESSES OF ENANTIOSELECTIVELY FORMING AN AMINOXY COMPOUND AND AN 1,2-OXAZINE COMPOUND | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2011-09-15 | — | — | US | disclosed |
| EP-2363498-A1 | METHOD FOR QUANTITATIVELY DETERMINING CHOLESTEROL IN LOW-DENSITY LIPOPROTEINS, REAGENT FOR QUANTITATIVE DETERMINATION, AND QUANTITATIVE DETERMINATION KIT | Kyowa Medex CO., LTD. (JP) | 2011-09-07 | — | — | EP | disclosed |
| US-20110081723-A1 | Detection of Explosives Through Luminescence | REDXDEFENSE, LLC (US) | 2011-04-07 | — | — | US | disclosed |
| WO-2010044920-A1 | DETECTION OF EXPLOSIVES THROUGH LUMINESCENCE | REDXDEFENSE, LLC (US) | 2010-04-22 | — | — | WO | disclosed |
| US-7625581-B2 | Tissue scaffolds for use in muscoloskeletal repairs | ETHICON, INC. (US) | 2009-12-01 | — | — | US | disclosed |
| US-20060287466-A1 | Method for production of prepolymers made from polysulphides and polyepoxides | THIOPLAST CHEMICALS GMBH & CO. KG (DE) | 2006-12-21 | — | — | US | disclosed |
| JP-2006244820-A | FUEL FOR FUEL CELL | TOSHIBA CORP | 2006-09-14 | — | — | JP | disclosed |
| US-7091191-B2 | Modified hyaluronic acid for use in musculoskeletal tissue repair | ETHICON, INC. (US) | 2006-08-15 | — | — | US | disclosed |
| US-20050147642-A1 | Tissue scaffolds for use in muscoloskeletal repairs | ENDO-SURGERY, INC. | 2005-07-07 | — | — | US | disclosed |
| US-20050137163-A1 | Modified hyaluronic acid for use in musculoskeletal tissue repair | ADVANCED TECHNOLOGIES AND REGENERATIVE MEDICINE, LLC | 2005-06-23 | — | — | US | disclosed |
| CN-1366709-A | Method for preparing porous SOG film | ULVAC INC (JP) | 2002-08-28 | — | — | CN | disclosed |
| US-4751299-A | Optically active β-lactams and method of their production | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1988-06-14 | — | — | US | disclosed |
| US-4684724-A | ANTIBIOTICS, BETA-LACTAMASE INHIBITORS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1987-08-04 | — | — | US | disclosed |
| EP-0083039-B1 | 4-CYANO-2-AZETIDINONES AND PRODUCTION THEREOF | Takeda Chemical Industries, Ltd. (JP) | 1986-03-19 | — | — | EP | disclosed |
| US-4560508-A | BETA-LACTAMASE INHIBITORS, ANINICROBIAL AGENT, CHEMICAL INTERMEDIATE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1985-12-24 | — | — | US | disclosed |
| EP-0144840-A2 | Optically active beta-lactams and method of their production | Takeda Chemical Industries, Ltd. (JP) | 1985-06-19 | — | — | EP | disclosed |
| US-4374042-A | QUATERNARY AMMONIUM COMPOUND AND AN ORGANIC IONIC COMPOUND | UOP INC. (US) | 1983-02-15 | — | — | US | disclosed |
| US-4308169-A | TREATMENT WITH AQUEOUS SOLUTION OF QUATERNARY AMMONIUM COMPOUND AND LINEAR IONIC COMPOUND | UOP INC. (US) | 1981-12-29 | — | — | US | disclosed |
| US-4299729-A | TREATING WITH AN AMMONIACAL SOLUTION OF A METAL CHELATE AND AN AQUEOUS SOLUTION OF A QUATERNARY AMMONIUM COMPOUND | UOP INC. (US) | 1981-11-10 | — | — | US | disclosed |
| US-4213877-A | Method of reactivating a catalytic composite of an adsorptive carrier material and a mercaptan oxidation catalyst | UOP INC. (US) | 1980-07-22 | — | — | US | disclosed |
| US-4203827-A | Process for treating sour petroleum distillates | UOP INC. (US) | 1980-05-20 | — | — | US | disclosed |
| US-4157312-A | QUATERNARY AMMONIUM, METAL CHELATE, SWEETENING | UOP INC. (US) | 1979-06-05 | — | — | US | disclosed |
| US-4157312-A | QUATERNARY AMMONIUM, METAL CHELATE, SWEETENING | UOP INC. (US) | 1979-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (14 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12344586-B2 | Process for the preparation of biphenylamines | DDT, AGPS, PAH | MMP1 4728/4885HTR2A 1796/4885KCNH2 1043/4885 |
| US-12128033-B2 | Synthetic methods for preparation of 4-(2-chloro-4-methoxy-5-methylphenyl)-n-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-n-prop-2-ynyl-1,3-thiazol-2-amine | CYP21A2, NR5A1, HSD3B1 | MMP1 3997/4885HTR2A 984/4885KCNH2 1814/4885 |
| US-20050137163-A1 | Modified hyaluronic acid for use in musculoskeletal tissue repair | CD44, MUSK, TNNC1 | MMP1 4/4885HTR2A 2399/4885KCNH2 801/4885 |
| US-20220380321-A1 | PROCESS FOR THE PREPARATION OF BIPHENYLAMINES | DDT, AGPS, PAH | MMP1 4728/4885HTR2A 1796/4885KCNH2 1043/4885 |
| US-11780817-B2 | Methods for preparing Favipiravir | FBP1, PFAS, FUCA2 | MMP1 4636/4885HTR2A 1099/4885KCNH2 1649/4885 |
| US-20260022311-A1 | SEMICONDUCTOR SUBSTRATE CLEANING COMPOSITION, AND METHOD FOR PRODUCING SEMICONDUCTOR SUBSTRATE USING SAME | SFN, SEM1, VAV1 | MMP1 857/4885HTR2A 2699/4885KCNH2 493/4885 |
| US-20210355090-A1 | METHODS FOR PREPARING FAVIPIRAVIR | FBP1, PFAS, FUCA2 | MMP1 4636/4885HTR2A 1099/4885KCNH2 1649/4885 |
| US-20230233534-A1 | SYNTHETIC METHODS FOR PREPARATION OF 4-(2-CHLORO-4-METHOXY-5-METHYLPHENYL)-N-[(1S)-2-CYCLOPROPYL-1-(3-FLUORO-4-METHYLPHENYL)ETHYL]-5-METHYL-N-PROP-2-YNYL-1,3-THIAZOL-2-AMINE | CYP21A2, NR5A1, HSD3B1 | MMP1 3997/4885HTR2A 984/4885KCNH2 1814/4885 |
| US-20110224429-A1 | PROCESSES OF ENANTIOSELECTIVELY FORMING AN AMINOXY COMPOUND AND AN 1,2-OXAZINE COMPOUND | AHR, CYP2S1, CYP1A1 | MMP1 4491/4885HTR2A 227/4885KCNH2 869/4885 |
| US-20250011297-A1 | PROCESS AND INTERMEDIATES FOR PREPARATION OF ISOFETAMID | IDH2, FH, SDHA | MMP1 2433/4885HTR2A 3508/4885KCNH2 2450/4885 |
| US-20240238257-A1 | SYNTHETIC METHODS FOR PREPARATION OF 4-(2-CHLORO-4-METHOXY-5-METHYLPHENYL)-N-[(1S)-2-CYCLOPROPYL-1-(3-FLUORO-4-METHYLPHENYL)ETHYL]-5-METHYL-N-PROP-2-YNYL-1,3-THIAZOL-2-AMINE | CYP21A2, NR5A1, HSD3B1 | MMP1 4345/4885HTR2A 799/4885KCNH2 1949/4885 |
| US-20230286932-A1 | SYNTHETIC METHODS FOR PREPARATION OF 4-(2-CHLORO-4-METHOXY-5-METHYLPHENYL)-N-[(1S)-2-CYCLOPROPYL-1-(3-FLUORO-4-METHYLPHENYL)ETHYL]-5-METHYL-N-PROP-2-YNYL-1,3-THIAZOL-2-AMINE | CYP21A2, NR5A1, HSD3B1 | MMP1 4345/4885HTR2A 799/4885KCNH2 1949/4885 |
| US-20140228564-A1 | PROCESSES OF ENANTIOSELECTIVELY FORMING AN AMINOXY COMPOUND AND AN 1,2-OXAZINE COMPOUND | AHR, CYP2S1, CYP1A1 | MMP1 4491/4885HTR2A 227/4885KCNH2 869/4885 |
| US-12582634-B2 | Synthetic methods for preparation of 4-(2-chloro-4-methoxy-5-methylphenyl)-n-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-n-prop-2-ynyl-1,3-thiazol-2-amine | CYP21A2, CYP11B1, NR5A1 | MMP1 2932/4885HTR2A 1937/4885KCNH2 533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.